DHR Trading Analysis - 10/26/2026 02:58 PM — TRU-SENTIMENT

News Headlines & Context

Danaher (DHR) recently completed its ex-dividend date on 2026-09-30 with a dividend rate of $1.60 and yield of 0.69%, reflecting steady shareholder returns in a low-yield environment.

Life sciences and diagnostics demand has shown signs of stabilization through Q3 2026, with broader sector rotation into defensive mega-caps amid macro uncertainty.

No major earnings catalyst is visible in the embedded data, but the next fiscal year end is 2025-12-01 per fundamentals, suggesting annual reporting cycles ahead.

Structural spin-off activity in the industrial/healthcare space may keep DHR in focus as a simplification candidate, though no specific event is confirmed in data.

Context: Headlines of stability align with the balanced options sentiment and modest RSI near 59.59, suggesting no acute bullish or bearish shock is priced.

Fundamental Analysis

Based strictly on provided FUNDAMENTALS data: Trailing P/E is 37.60 with trailing EPS of $6.13. Market cap is $163,627,021,360.00 with shares outstanding of 702,986,000.00. Dividend yield is 0.69% with rate $1.60 and ex-dividend 2026-09-30.

Revenue growth (YoY), profit margins (gross/operating/net), ROE, debt/equity, and free cash flow are null in data — not available for trend analysis. PEG ratio is null; cannot compare valuation via PEG. Forward P/E and target mean price are null; no analyst consensus captured.

Key metrics available: Beta 0.58 (low systemic risk), 52-week high $242.80, low $160.93, institutional ownership 63.51%, average volume 4,866,000.00, historical volatility 30.06%.

Fundamentals show a rich trailing P/E of 37.60 vs absent peer PEG, but low beta and solid institutional base support a defensive tilt. This diverges mildly from technical uptrend (price above SMAs) as valuation lacks growth confirmation in data.

Current Market Position

Current price per indicators is $229.50 (2026-10-23). Minute bars show 2026-10-23 14:30 open $229.17, low $225.60, close $227.16; by 2026-10-26 14:30 close $232.76, high $232.76, indicating intraday uptrend over the window.

Recent daily history: 30-day range high $238.13 (2026-10-22), low $199.09 (2026-09-14). Price sits in upper third of 30-day range. Last daily close $229.50 vs SMA_20 $223.24 and SMA_50 $216.14.

Intraday momentum: From $227.16 (10-23) to $232.76 (10-26) shows steady buying; volume on last bar 32,725 vs early 1,564,005 suggests thinner late-session push but positive drift.

Technical Analysis

SMA alignment: 5-day $228.29 > 20-day $223.24 > 50-day $216.14 — bullish stacking, no bearish cross. RSI 59.59 shows moderate momentum, not overbought (<70). MACD line 4.24 above signal 3.39, histogram 0.85 positive — mild bullish momentum.

Bollinger: Price $229.50 between mid $223.24 and upper $234.57 — upper-half expansion, no squeeze. 30-day range: price $229.50 is 74.2% up the $199.09–$238.13 band, near resistance zone.

True Sentiment Analysis (Delta 40-60 Options)

Per True Sentiment options (2026-10-26): Sentiment "Balanced". Call dollar volume $124,080.00 (44.8%), Put dollar volume $153,170.00 (55.2%), total $277,250.00. Contracts: calls 109, puts 82; trades calls 20, puts 7.

Pure directional conviction (delta 40-60) shows slight put dollar bias but more call trades — mixed. Near-term expectation: neutral with mild defensive put notional. Divergence: technicals bullish (SMA/MACD) while options flow balanced — no confirmation of upside breakout.

Options spread engine returned no recommendation: "Balanced sentiment - no clear directional bias" — suggests neutral strategies or wait.

Key Price Levels (Observational Only)